Amgen announced that results from the PRIME ‘203’ and ‘181’ pivotal Phase 3 trials
Amgen announced that results from the PRIME '203' and '181' pivotal Phase 3 trials evaluating...
Bristol-Myers Squibb announced results from a randomized, double-blind Phase 3 clinical study in adults...
Bristol-Myers Squibb Company and AstraZeneca announced results from a randomized, double-blind Phase 3 clinical study...
